Belvedere Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,700
Closed -$109K 1012
2024
Q4
$109K Buy
+2,700
New +$154K ﹤0.01% 501
2024
Q3
Sell
-400
Closed -$21.2K 955
2024
Q2
$21.2K Sell
400
-2,200
-85% -$144K ﹤0.01% 559
2024
Q1
$213K Sell
2,600
-2,900
-53% -$129K ﹤0.01% 327
2023
Q4
$102K Hold
5,500
﹤0.01% 453
2023
Q3
$60.9K Sell
5,500
-400
-7% -$5.72K ﹤0.01% 402
2023
Q2
$95.6K Sell
5,900
-7,500
-56% -$157K ﹤0.01% 437
2023
Q1
$223K Buy
13,400
+2,100
+19% +$21.7K ﹤0.01% 299
2022
Q4
$106K Buy
+11,300
New +$50.4K ﹤0.01% 460

Other funds holding VKTX